International circumpolar surveillance interlaboratory quality control program for serotyping Haemophilus influenzae and serogrouping Neisseria meningitidis, 2005 to 2009

Journal of Clinical Microbiology

Volumn 50, Issue 3, 2012, Pages 651-656

  Tsang, Raymond S W ^a   Rudolph, Karen ^b   Lovgren, Marguerite ^c   Bekal, Sadjia ^d   Lefebvre, Brigitte ^d   Lambertsen, Lotte ^e   Zulz, Tammy ^b   Bruce, Michael ^b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^d INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^e STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTINATION TEST; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CANADA; DISEASE SURVEILLANCE; HAEMOPHILUS INFLUENZAE; HEALTH PROGRAM; INTERLABORATORY QUALITY CONTROL PROGRAM; LABORATORY; MULTIPLEX POLYMERASE CHAIN REACTION; NEISSERIA MENINGITIDIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; SEROTYPING; UNITED STATES;

CANADA; DENMARK; HAEMOPHILUS INFLUENZAE; HUMANS; NEISSERIA MENINGITIDIS; QUALITY CONTROL; SEROTYPING;

EID: 84857413311     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05084-11     Document Type: Article

References (42)

1. Adam HJ, et al. 2010. Changing epidemiology of invasive Haemophilus influenzae disease in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine 28:4073-4078.
2. Andersen J, Berthelsen L, Jensen BB, Lind I. 1998. Dynamics of the meningococcal carrier state and characteristics of the carrier strains: a longitudinal study within three cohorts of military recruits. Epidemiol. Infect. 121:85-94. (Pubitemid 28423333)
3. Ashton FE, Ryan A, Diena BB, Frasch CE. 1979. Evaluation of the antiserum agar method for the serogroup identification of Neisseria meningitidis. Can. J. Microbiol. 25:784-787. (Pubitemid 9213221)
4. Bath S, et al. 2002. Progress towards elimination of Haemophilus influenzae type b invasive disease among infants and children - United States, 1998-2000. MMWR Morb. Mortal. Wkly. Rep. 51:234-237.
5. Bennett DE, Mulhall RM, Cafferkey MT. 2004. PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z. J. Clin. Microbiol. 42:1764-1765. (Pubitemid 38500834)
6. Bhattacharjee AK, Jennings HJ, Kenny CP, Martin A, Smith IC. 1976. Structural determination of the polysaccharide antigens of Neisseria meningitidis serogroup Y, W-135 and BO1. Can. J. Biochem. 54:1-8.
7. Bokermann S, Zanella RC, Lemos APS, de Andrade ALSS, Brandileone MCC. 2003. Evaluation of methodology for serotyping invasive and nasopharyngeal isolates of Haemophilus influenzae in the ongoing surveillance in Brazil. J. Clin. Microbiol. 41:5546-5550. (Pubitemid 37543243)
8. Borrow R, et al. 1997. Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiol. Infect. 118:111-117. (Pubitemid 27170802)
9. Borrow R, et al. 1998. siaD PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal infections. FEMS Microbiol. Lett. 159:209-214. (Pubitemid 28073892)
10. Brown VM, et al. 2009. Invasive Haemophilus influenzae disease caused by non-type b strains in Northwestern Ontario, Canada, 2002-2008. Clin. Infect. Dis. 49:1240-1243.
11. Bruce MG, et al. 2008. Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000-2005. Emerg. Infect. Dis. 14:48-55.
12. Canadian Immunization Committee, Public Health Agency of Canada. 2010. Advice for consideration of quadrivalent (A, C, Y, W-135) meningococcal conjugate vaccine, for use by provinces and territories. Can. Commun. Dis. Rep. 26(Suppl. 2):1-35.
13. Claus H, Matsunaga W, Vogel U. 2010. Molecular discrimination between Neisseria meningitidis serogroups W135 and Y based on the nucleotide recognition domain sequence of the capsule polymerase. J. Clin. Microbiol. 48:3459-3460.
14. Dworkin MS, Park L, Borchardt SM. 2007. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons ≥65 years old. Clin. Infect. Dis. 44:810-816. (Pubitemid 46365305)
15. Falla TJ, et al. 1994. PCR for capsule typing of Haemophilus influenzae. J. Clin. Microbiol. 32:2382-2386. (Pubitemid 24284632)
16. Fallon RJ, Brown W, Scott AC. 1971. Infections caused by meningococci of serogroup Z. Lancet 297:783-784.
17. Gagneux SP, et al. 2002. Prospective study of a serogroup X Neisseria meningitidis outbreak in Northern Ghana. J. Infect. Dis. 185:618-626. (Pubitemid 34171466)
18. Gonin P, Lorange M, Delage G. 2000. Performance of a multiplex PCR for the determination of Haemophilus influenzae capsular types in the clinical microbiology laboratory. Diagn. Microbiol. Infect. Dis. 37:1-4. (Pubitemid 30224515)
19. Gudlavalleti SK, et al. 2004. The Neisseria meningitidis serogroup A capsular polysaccharide O-3 and O-4 acetyltransferase. J. Biol. Chem. 279:42765-42773. (Pubitemid 39372164)
20. Ingram DL, Collier AM, Fendergrass E, King SH. 1979. Methods for serotyping nasopharyngeal isolates of Haemophilus influenzae: slide agglutination, quelling reaction, countercurrent immunoelectrophoresis, latex agglutination, and antiserum agar. J. Clin. Microbiol. 9:570-574. (Pubitemid 9158410)
21. Kroll JS, Hopkins I, Moxon ER. 1988. Capsule loss in H. influenzae type b occurs by recombination-mediated disruption of a gene essential for polysaccharide export. Cell 53:347-356.
22. LaClaire LL, et al. 2002. Serotyping discrepancies in Haemophilus influenzae type b disease - United States, 1998-1999. MMWR Morb. Mortal. Wkly. Rep. 51:706-707.
23. LaClaire LL, et al. 2003. Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing. J. Clin. Microbiol. 41:393-396. (Pubitemid 36098605)
24. Ladhani S, et al. 2010. Invasive Haemophilus influenzae disease, Europe, 1996-2006. Emerg. Infect. Dis. 16:455-463.
25. Leinonen M, Sivonen A. 1979. Serological grouping of meningococci and encapsulated Haemophilus influenzae strains by latex agglutination. J. Clin. Microbiol. 10:404-408. (Pubitemid 10250165)
26. Lorick SA, et al. 2009. Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: demand, supply and seasonality. BMC Infect. Dis. 9:175. doi:10.1186/1471-2334-9-175.
27. Mothershed EA, et al. 2004. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J. Clin. Microbiol. 42:320-328. (Pubitemid 38082739)
28. Parkinson AJ, Butler JC. 18 November 2004, posting date. Prevention and control of emerging infectious diseases in the Arctic: establishing an international circumpolar surveillance system. EpiNorth. http://www.epinorth. org/eway/default.aspx?pid=230&trg=Area-5328&MainArea-5260= 5328&Area-5328=5273:44863::0:5326:1:::0:0.
29. Parkinson AJ, Bruce MG, Zulz T. 2008. International Circumpolar Surveillance, an Arctic network for the surveillance of infectious diseases. Emerg. Infect. Dis. 14:18-24.
30. Reasonover A, et al. 2011. The International Circumpolar Surveillance interlaboratory quality control program for Streptococcus pneumoniae, 1999 to 2008. J. Clin. Microbiol. 49:138-143.
31. Rudolph KM, et al. 2011. Invasive meningococcal disease caused by Neisseria meningitidis strains expressing both serogroup Y and W135 antigenic specificities. J. Clin. Microbiol. 49:472-473.
32. Qudri SMH, Talbot D. 1983. Evaluation of the Phadebact coagglutination test for the rapid serotyping of Haemophilus influenzae. Med. Microbiol. Immunol. 172:161-164. (Pubitemid 14245312)
33. Sadarangani M, Pollard AJ. 2010. Serogroup B meningococcal vaccines - an unfinished story. Lancet Infect. Dis. 10:112-124.
34. Satola SW, Collins JT, Napier R, Farley MM. 2007. Capsule gene analysis of invasive Haemophilus influenzae: accuracy of serotyping and prevalence of IS1016 among nontypeable isolates. J. Clin. Microbiol. 45:3230-3238. (Pubitemid 47585644)
35. Swartley JS, et al. 1998. Characterization of the gene cassette required for biosynthesis of the (α1→6)-linked N-acetyl-d-mannosamine-1- phosphate capsule of serogroup A Neisseria meningitidis. J. Bacteriol. 180:1533-1539. (Pubitemid 28125739)
36. Taha MK. 2000. Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. J. Clin. Microbiol. 38:855-857.
37. Tsang RSW, Zollinger WD. 2005. Serological specificities of murine monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 12:152-156.
38. Tsang RSW, et al. 2007. Characterization of invasive Haemophilus influenzae disease in Manitoba, Canada, 2000-2006: invasive disease due to non-type b strains. Clin. Infect. Dis. 44:1611-1614. (Pubitemid 46871508)
39. Tsang RSW, et al. 2008. Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135. Can. J. Microbiol. 54:229-234. (Pubitemid 351398621)
40. van der Ende A, Schuujrman IGA, Hopman CTP, Fijen CAP, Dankert J. 1995. Comparison of commercial diagnostic tests for identification of serogroup antigens of Neisseria meningitidis. J. Clin. Microbiol. 33:3326-3327.
41. Wachter E, Brown AE, Kiehn TE, Lee BJ, Armstrong D. 1985. Neisseria meningitidis serogroup 29E (Z=) septicemia in a patient with far advanced multiple myloma (plasma cell leukemia). J. Clin. Microbiol. 21:464-466. (Pubitemid 15168672)
42. Zulz T, Bruce MG, Parkinson AJ. 2009. International Circumpolar Surveillance. Prevention and control of infectious diseases: 1999-2008. Circumpolar Health Suppl. 4:13-30.